Wednesday 16 July 2014 10:30 – 12:00
Track 2 - Rethinking Mood Therapeutics- Novel pharmacological approaches for Anxiety and Depression
Chair: Nicolas Singewald & John Cryan
Rescue of impaired fear extinction by targeting epigenetic mechanisms in a genetic mouse model
Nicolas Singewald
Translational support of a role of endocannabinoids in anxiety and its treatment
Andrew Holmes
Revising antidepressant therapy: from serotonin to glutamate
Greger Wegener
Behavioural and biological validation of an animal model of obsessive-compulsive disorder (OCD)
Brian Harvey
microRNAs as Novel therapeutic targets for anxiety and depression
John Cryan